IP Verse

Individualized Vaccines For Cancer

Patent No. EP3892295 (titled "Individualized Vaccines For Cancer") was filed by Biontech on May 23, 2012. The application was issued on Apr 26, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WITHERS & ROGERS LLPJONES NICHOLASWRIGHT HOWARD WALLIN NICHOLASJan 25, 2024TOMBLING

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3892295

BIONTECH
Application Number
EP21168360A
Filing Date
May 23, 2012
Status
Opposition Rejected
May 29, 2025
Publication Date
Apr 26, 2023
External Links
Slate, Register , Google Patents